Literature DB >> 9733881

The S2 gene of equine infectious anemia virus is dispensable for viral replication in vitro.

F Li1, B A Puffer, R C Montelaro.   

Abstract

Equine infectious anemia virus (EIAV) contains the simplest genome among lentiviruses in that it encodes only three putative regulatory genes (S1, S2, S3) in addition to the canonical gag, pol, and env genes, presumably reflecting its limited tropism to cells of monocyte/macrophage lineage. Tat and Rev functions have been assigned to S1 and S3, respectively, but the specific function for the S2 gene has yet to be determined. Thus, the function of S2 in virus replication in vitro was investigated by using an infectious molecular viral clone, EIAVUK. Various EIAVUK mutants lacking S2 were constructed, and their replication kinetics were examined in several equine cell culture systems, including the natural in vivo target equine macrophage cells. The EIAV S2 mutants showed replication kinetics similar to those of the parental virus in all of the tested primary and transformed equine cell cultures, without any detectable reversion of mutant genomes. The EIAVUK mutants also showed replication kinetics similar to those of the parental virus in an equine blood monocyte differentiation-maturation system. These results demonstrate for the first time that the EIAV S2 gene is not essential and does not appear to affect virus infection and replication properties in target cells in vitro.

Entities:  

Mesh:

Year:  1998        PMID: 9733881      PMCID: PMC110207     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Analysis of the vif gene of feline immunodeficiency virus.

Authors:  B L Shacklett; P A Luciw
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

2.  Equine infectious anemia virus tat: insights into the structure, function, and evolution of lentivirus trans-activator proteins.

Authors:  P Dorn; L DaSilva; L Martarano; D Derse
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Identification of sequences encoding the equine infectious anemia virus tat gene.

Authors:  S Noiman; A Gazit; O Tori; L Sherman; T Miki; S R Tronick; A Yaniv
Journal:  Virology       Date:  1990-05       Impact factor: 3.616

4.  Monocyte maturation controls expression of equine infectious anemia virus.

Authors:  W Maury
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Induction of cell differentiation by human immunodeficiency virus 1 vpr.

Authors:  D N Levy; L S Fernandes; W V Williams; D B Weiner
Journal:  Cell       Date:  1993-02-26       Impact factor: 41.582

6.  Equine infectious anemia virus trans-regulatory protein Rev controls viral mRNA stability, accumulation, and alternative splicing.

Authors:  L Martarano; R Stephens; N Rice; D Derse
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.

Authors:  N K Heinzinger; M I Bukrinsky; S A Haggerty; A M Ragland; V Kewalramani; M A Lee; H E Gendelman; L Ratner; M Stevenson; M Emerman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-19       Impact factor: 11.205

8.  Translation of equine infectious anemia virus bicistronic tat-rev mRNA requires leaky ribosome scanning of the tat CTG initiation codon.

Authors:  R Carroll; D Derse
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection.

Authors:  M E Rogel; L I Wu; M Emerman
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

10.  Equine infectious anemia virus gene expression: characterization of the RNA splicing pattern and the protein products encoded by open reading frames S1 and S2.

Authors:  R L Schiltz; D S Shih; S Rasty; R C Montelaro; K E Rushlow
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

View more
  23 in total

1.  Characterization of a cytolytic strain of equine infectious anemia virus.

Authors:  Wendy Maury; Patrick J Wright; Sarahann Bradley
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies.

Authors:  F Li; C Leroux; J K Craigo; S J Cook; C J Issel; R C Montelaro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Envelope variation as a primary determinant of lentiviral vaccine efficacy.

Authors:  Jodi K Craigo; Baoshan Zhang; Shannon Barnes; Tara L Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-10       Impact factor: 11.205

4.  Genomic analysis of an effective lentiviral vaccine-attenuated equine infectious anemia virus vaccine EIAV FDDV13.

Authors:  Xu Qi; Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Rongxian Shen; Fenglong Wang; Xiangang Kong; Zhiqiang Su; Jianhua Zhou
Journal:  Virus Genes       Date:  2010-06-05       Impact factor: 2.332

5.  Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines.

Authors:  Jodi K Craigo; Shannon Durkin; Timothy J Sturgeon; Tara Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Vaccine       Date:  2006-09-22       Impact factor: 3.641

6.  Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication.

Authors:  Feng Li; Chaoping Chen; Bridget A Puffer; Ronald C Montelaro
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

7.  Serological method using recombinant S2 protein to differentiate equine infectious anemia virus (EIAV)-infected and EIAV-vaccinated horses.

Authors:  Sha Jin; Charles J Issel; Ronald C Montelaro
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

8.  EIAV S2 enhances pro-inflammatory cytokine and chemokine response in infected macrophages.

Authors:  Lina Covaleda; Frederick J Fuller; Susan L Payne
Journal:  Virology       Date:  2009-11-28       Impact factor: 3.616

9.  Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.

Authors:  Jörg Zielonka; Ignacio G Bravo; Daniela Marino; Elea Conrad; Mario Perković; Marion Battenberg; Klaus Cichutek; Carsten Münk
Journal:  J Virol       Date:  2009-05-20       Impact factor: 5.103

10.  Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.

Authors:  Daniel C Farley; Richard Bannister; Marie A Leroux-Carlucci; Nerys E Evans; James E Miskin; Kyriacos A Mitrophanous
Journal:  Hum Gene Ther Methods       Date:  2012-11-02       Impact factor: 2.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.